Target intelligence / Profile preview

Regenerating islet-derived protein 4 (REG4)

Target
REG4
Molecular classification
Secreted protein (not membrane-bound), C-type lectin family protein, Lectin (carbohydrate-binding), Sometimes described as a "growth factor" for pancreatic beta cells
01

Overview

Regenerating islet-derived protein 4 (REG4) is a secreted C-type lectin protein encoded by the REG4 gene on human chromosome 1. REG4 is expressed in various tissues, notably the gastrointestinal tract, pancreas, and ovary, and upregulated in several types of malignancies. It promotes cancer cell proliferation, survival, migration, and resistance to therapy through activation of EGFR/Akt and β-catenin-dependent pathways and interacts with cell surface molecules such as CD44 and G protein-coupled receptor 37. REG4 is emerging both as a promising biomarker of cancer progression and prognosis and as a potential therapeutic target. Its physiological function includes modulation of inflammation and tissue regeneration, with aberrant expression contributing to the aggressive behavior of tumors.

Other names
Regenerating family member 4REG-4REG IVREG-IVRELPGISPGastrointestinal secretory proteinRegenerating gene type IVREG-like protein
02

Mechanism of action

Blockade of REG4 function (e.g., anti-REG4 antibodies can inhibit migration and invasion in cancer models); Modulation of downstream signaling (REG4 activates cancer cell survival pathways via EGFR/Akt, AP-1, and β-catenin/TCF-4, so inhibitors of these could indirectly intersect REG4 activity)

03

Biological functions

Cell proliferationAnti-apoptosis (inhibition of programmed cell death)Macrophage polarization (promotes M2 type response)Infection response (response to bacteria)Inflammatory and metaplastic response of gastrointestinal epitheliumChemoresistance (in cancer cells)Cancer stem cell maintenanceOrganoid formation in gut stem cells
04

Disease associations

Cancer (especially gastric, colorectal, pancreatic, gallbladder, ovarian, urothelial, lung neuroendocrine, and signet ring cell carcinomas)InflammationUlcerative colitisInfection (response to pathogenic bacteria)Cystadenoma
05

Safety considerations

Selectivity: REG4 is expressed in some normal tissues (brain cortex, GI tract, pancreas, spleen, ovary), so therapeutic targeting may risk off-tumor effectsPotential for chemoresistance: Overexpression correlates with reduced sensitivity to radiochemotherapy in cancers, which is a therapeutic challenge
06

Interacting drugs

No approved drugs directly targeting REG4 are currently documented. Most studies focus on REG4 as a biomarker or experimental target. Research explores anti-REG4 antibodies and recombinant REG4 protein, but these are not clinically approved therapies.
07

Biomarkers

REG4 protein overexpression (serves as a biomarker for tumorigenesis, progression, and poor prognosis in various cancers, especially neuroendocrine and signet ring cell subtypes)REG4 immunoreactivity in tissue or lavage fluid may also be used for early cancer detection or monitoring treatment response

Beyond the preview

Go deeper on Regenerating islet-derived protein 4 (REG4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenerating islet-derived protein 4 (REG4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call